Saturday, February 2, 2013

• Celsion Stock Blown Apart On Thermodox Phase III Dataat Seeking Alpha (Sat, Feb 2)

Friday, February 1, 2013

• 3 Horrendous Health-Care Stocks This Weekat Motley Fool (Fri, Feb 1)
• CELSION CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online (Fri, Feb 1)
• Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year HighMarketwired (Fri, Feb 1)
• Today's Market News To Trade On: 5 Stocks Moving On Newsat Seeking Alpha (Fri, Feb 1)
• Biotech Stock Mailbag: Celsion, Navidea, AP Pharma, Sareptaat TheStreet (Fri, Feb 1)

Thursday, January 31, 2013

• Celsion's 'Bad Beat' : 4 'Tells' That Longs Missedat Seeking Alpha (Thu, Jan 31)
• Why Celsion Shares Were Evisceratedat Motley Fool (Thu, Jan 31)
• Celsion Phase III Failure: What Went Wrong?at Seeking Alpha (Thu, Jan 31)
• Why Shares of Celsion Got Crushed Todayat Motley Fool (Thu, Jan 31)
• Celsion Shares Nosedive After Cancer Therapy Failsat Minyanville (Thu, Jan 31)
• Law Firm Brower Piven Announces Investigation of Investor Securities Fraud Against Celsion CorporationBusiness Wire (Thu, Jan 31)
• Can Celsion Survive After Imploding Over Phase III Results?at Seeking Alpha (Thu, Jan 31)
• Celsion Collapses on Failure: What's Next?at Motley Fool (Thu, Jan 31)
• CELSION CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements anEDGAR Online (Thu, Jan 31)
• Celsion Announces Results of Phase III HEAT Study of ThermoDox® in Primary Liver CancerPR Newswire (Thu, Jan 31)

Wednesday, January 30, 2013

• Celsion Corporation to Host Conference Call and Webcast on January 31, 2013 at 8:00 AM EST to Present Top-Line Data from its Pivotal Phase III HEAT StudyPR Newswire (Wed, Jan 30)

Tuesday, January 29, 2013

• Buy, Sell, or Hold: Keryx Biopharmaceuticalsat Motley Fool (Tue, Jan 29)

Monday, January 28, 2013

• Biopharma Catalyst Trades To Watch For This Weekat Seeking Alpha (Mon, Jan 28)
• This Week in Biotech: Part 1at Motley Fool (Mon, Jan 28)
• Seeking Alpha Author Used Multiple Aliases to Tout Biotech Stocksat TheStreet (Mon, Jan 28)
• Phase III Data Will Rock These 2 Bio Stocksat Seeking Alpha (Mon, Jan 28)

Sunday, January 27, 2013

• A Look at Three Biotech Moversat Motley Fool (Sun, Jan 27)
• China Biotech In Review: 2012 China Life Science VC, M&A, And Partnering Climbat Seeking Alpha (Sun, Jan 27)

Friday, January 25, 2013

• Assessing Risk Ahead of Company Changing Dataat Motley Fool (Fri, Jan 25)

Add CLSN News to My Yahoo!